Skip to main content
Articles & Publications , Eleanor Row

3 Key Trends Shaping Our Industry: Contract Pharma Thought Leadership Feature with Eleanor Row

Eleanor Row

What are the "3 Key Trends" that are shaping the CDMO industry in 2023 and beyond?

From integrated drug development services to sterile drug manufacturing, our Executive Director of Commercial, Dr. Eleanor Row, touches on it all in Contract Pharma's latest thought leadership article "3 Key Trends that are Shaping the CDMO Industry"

Traditionally, the CDMO/CRO industry has been highly siloed. Mainly this has been down to a large number of organizations outsourcing or operating almost completely in isolation. At Quotient Sciences we see substantial benefits around forming collaborations with other service providers in the marketplace, such as Charles River. With collaboration in place alongside our end-to-end integrated programs, we see more informed decision-making, reduced risk, condensed timelines, and reduced costs.

Continue reading the article on Contract Pharma

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, commercial manufacturing, Dr. Helen Baker, Dr. Richard Castledine Dr. Helen Baker and Dr. Richard Castledine contribute to Pharmaceutical Technology's 'Poor API Quality Threatens a Healthy Supply' By: Dr. Helen Baker and Dr. Richard Castledine
Read More
News & Announcements, Articles & Publications, Thierry Van Nieuwenhove Thierry Van Nieuwenhove on the Future of CDMO Partnerships By: Thierry Van Nieuwenhove
Read More
News & Announcements, Translational Pharmaceutics®, Articles & Publications BioPharm International interviews Helen Baker about how Quotient Sciences is optimizing drug development
Read More
Get in touch
Humanity can't afford to wait, so neither can we.